Levodropropizine structure
|
Common Name | Levodropropizine | ||
---|---|---|---|---|
CAS Number | 99291-25-5 | Molecular Weight | 236.310 | |
Density | 1.2±0.1 g/cm3 | Boiling Point | 412.7±34.0 °C at 760 mmHg | |
Molecular Formula | C13H20N2O2 | Melting Point | 102-106ºC | |
MSDS | N/A | Flash Point | 220.9±24.3 °C |
Use of LevodropropizineLevodropropizine (DF-526) is a histamine receptor inhibitor, Levodropropizine is an effective and very well tolerated peripheral antitussive drug. |
Name | levodropropizine |
---|---|
Synonym | More Synonyms |
Description | Levodropropizine (DF-526) is a histamine receptor inhibitor, Levodropropizine is an effective and very well tolerated peripheral antitussive drug. |
---|---|
Related Catalog | |
References |
Density | 1.2±0.1 g/cm3 |
---|---|
Boiling Point | 412.7±34.0 °C at 760 mmHg |
Melting Point | 102-106ºC |
Molecular Formula | C13H20N2O2 |
Molecular Weight | 236.310 |
Flash Point | 220.9±24.3 °C |
Exact Mass | 236.152481 |
PSA | 46.94000 |
LogP | 0.46 |
Vapour Pressure | 0.0±1.0 mmHg at 25°C |
Index of Refraction | 1.577 |
Storage condition | Refrigerator |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
HS Code | 2933599090 |
---|
~% Levodropropizine CAS#:99291-25-5 |
Literature: US4699911 A1, ; |
~47% Levodropropizine CAS#:99291-25-5 |
Literature: Giani; Marinone; Melillo; Borsa; Tonon Arzneimittel-Forschung/Drug Research, 1988 , vol. 38, # 8 p. 1139 - 1141 |
~% Levodropropizine CAS#:99291-25-5 |
Literature: Arzneimittel-Forschung/Drug Research, , vol. 38, # 8 p. 1139 - 1141 |
Precursor 3 | |
---|---|
DownStream 0 |
HS Code | 2933599090 |
---|---|
Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
Efficacy and tolerability of levodropropizine and dropropizine in children with non-productive cough.
J. Int. Med. Res. 23(3) , 175-83, (1995) The antitussive efficacy and tolerability of dropropizine and of its enantiomer levodropropizine were evaluated in children with non-productive cough; 258 were evaluable for tolerability and 254 for e... |
|
Efficacy of levodropropizine in pediatric cough.
Pulm. Pharmacol. Ther. 25(5) , 337-42, (2012) Cough in children is among the most common problems managed by pediatricians, and occurs more frequently in preschool than in older children. Most acute episodes of cough are due to viral upper respir... |
|
Studies on the human metabolism and the toxicologic detection of the cough suppressant dropropizine in urine using gas chromatography-mass spectrometry.
Ther. Drug Monit. 26(4) , 441-9, (2004) Studies are described on the metabolism and the toxicologic analysis of the nonopioid cough suppressant dropropizine [R,S-3-(4-phenyl-1-piperazinyl)1,2-propandiol, DRO] in human urine using gas chroma... |
(S)-dropropizine |
Levdropropizina |
1,2-Propanediol,3-(4-phenyl-1-piperazinyl)-,(R) |
(-)-Dropropizine |
rapitux |
1,2-Propanediol, 3-(4-phenyl-1-piperazinyl)-, (2S)- |
(+)-Dropropizine |
(2S)-3-(4-phenylpiperazin-1-yl)propane-1,2-diol |
(R)-3-(4-Phenylpiperazin-1-yl)propane-1,2-diol |
Levdropropizina [Latin,Spanish] |
(2S)-3-(4-Phenyl-1-piperazinyl)-1,2-propanediol |
(R)-3-(4-Phenyl-1-piperazinyl)-1,2-propanediol |
Levodropropizine |
Dropropizine S-form |